Revvity Gene Delivery (SIRION Biotech)
Booth number: C-18-1
www.sirion-biotech.com
About us
Revvity Gene Delivery (formerly SIRION Biotech) is a leading supplier of viral vector technologies engineering a new generation of optimized viral vectors for safer and more efficacious cell and gene therapies.
We guide our clients through the entire CGT value chain:
Capsid evolution and clinical vector design to reduce vector dose and improve therapeutic success
Process and development experience for individual optimization
Manufacture of high-quality viral vectors for late preclinical applications
We also offer LentiBOOST®, a highly effective lentiviral transduction enhancer that boosts efficiency by up to 90% in a wide range of clinically relevant cell types, including CD34+ hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), neuronal stem cells, primary T cells, hard-to-transduce murine T cells, NK cells, and fibroblasts.
LentiBOOST is currently included in over 50 Phase III and I/II clinical trials and one approved cell therapy medication.
Address
Am Haag 6
82166 Graefelfing
Germany
Phone: +49 89 700961990
Products & Services
Viral vector technologies (AAV, LV, AV)
Engineering a new generation of optimized viral vectors for safer and more efficacious cell and gene therapies.
Capsid evolution and clinical vector design to reduce vector dose and improve therapeutic success
Process and development experience for individual optimization
Manufacture of high-quality viral vectors for late preclinical applications
High purity AAV empty capsids
LentiBOOST®, a highly effective lentiviral transduction enhancer that boosts efficiency by up to 90% in a wide range of clinically relevant cell types, including CD34+ hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), neuronal stem cells, primary T cells, hard-to-transduce murine T cells, NK cells, and fibroblasts.
LentiBOOST is currently included in over 50 Phase III and I/II clinical trials and one approved cell therapy medication.